首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
【2h】

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy

机译:在可能发展与药物相关的下颌骨坏死风险的患者中意识到这一点(主要预防策略)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The quality of life, in itself, in cancer patients or in osteoporotic individuals, without even considering the side effects of the medication in the first place, has a considerable negative impact on the clinical outcome. The Medication Related Osteonecrosis of the Jaw (MRONJ), in the maxillofacial region, although rare, needs to be addressed with the prime importance. One of the key components of any given preventive treatment strategy is to, create awareness about the medication related unwanted effects, among health care professionals and patients.
机译:癌症患者或骨质疏松症患者的生活质量本身,甚至根本没有考虑药物的副作用,对临床结果具有相当大的负面影响。上颌面区域的与药物相关的下颌骨坏死(MRONJ),尽管很罕见,但必须首先解决。任何给定的预防性治疗策略的关键组成部分之一,是要使医疗保健专业人员和患者对与药物相关的不良影响有所了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号